These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29132916)

  • 1. Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease.
    Kurochkin IV; Guarnera E; Berezovsky IN
    Trends Pharmacol Sci; 2018 Jan; 39(1):49-58. PubMed ID: 29132916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
    Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
    J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.
    Tundo GR; Grasso G; Persico M; Tkachuk O; Bellia F; Bocedi A; Marini S; Parravano M; Graziani G; Fattorusso C; Sbardella D
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulysin: an allosteric enzyme as a target for Alzheimer's disease.
    Song ES; Hersh LB
    J Mol Neurosci; 2005; 25(3):201-6. PubMed ID: 15800373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
    Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review.
    Azam MS; Wahiduzzaman M; Reyad-Ul-Ferdous M; Islam MN; Roy M
    Pharm Res; 2022 Apr; 39(4):611-629. PubMed ID: 35378698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
    Zhang H; Liu D; Huang H; Zhao Y; Zhou H
    Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
    Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
    PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease.
    Li G; Kim C; Kim J; Yoon H; Zhou H; Kim J
    J Alzheimers Dis; 2015; 46(1):109-22. PubMed ID: 25720399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
    Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
    Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
    Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
    Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.